CODEX: COunterfactual Deep learning for the in-silico EXploration of cancer cell line perturbations
Preprint
Abstract
Motivation: High-throughput screens (HTS) provide a powerful tool to decipher the causal effects of chemical and genetic perturbations on cancer cell lines. Their ability to evaluate a wide spectrum of interventions, from single drugs to intricate drug combinations and CRISPR-interference, has established them as an invaluable resource for the development of novel therapeutic approaches. Nevertheless, the combinatorial complexity of potential interventions makes a comprehensive exploration intractable. Hence, prioritizing interventions for further experimental investigation becomes of utmost importance. Results: We propose CODEX as a general framework for the causal modeling of HTS data, linking perturbations to their downstream consequences. CODEX relies on a stringent causal modeling strategy based on counterfactual reasoning. As such, CODEX predicts drug-specific cellular responses, comprising cell survival and molecular alterations, and facilitates the in-silico exploration of drug combinations. This is achieved for both bulk and single-cell HTS. We further show that CODEX provides a rationale to explore complex genetic modifications from CRISPR-interference in silico in single cells. Availability and Implementation: Our implementation of CODEX is publicly available at https://github.com/sschrod/CODEX . All data used in this article are publicly available.Keywords
This publication has 27 references indexed in Scilit:
- Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seqCell, 2022
- A community challenge for a pancancer drug mechanism of action inference from perturbational profile dataCell Reports Medicine, 2022
- More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screensPharmacology & Therapeutics, 2018
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- A Landscape of Pharmacogenomic Interactions in CancerCell, 2016
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency ModelComputational and Structural Biotechnology Journal, 2015
- A community effort to assess and improve drug sensitivity prediction algorithmsNature Biotechnology, 2014
- Structure and dynamics of molecular networks: A novel paradigm of drug discoveryPharmacology & Therapeutics, 2013
- Combinatorial drug therapy for cancer in the post-genomic eraNature Biotechnology, 2012
- Estimating causal effects of treatments in randomized and nonrandomized studies.Journal of Educational Psychology, 1974